A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia

Brain, Behavior, and Immunity

Volumn 26, Issue 3, 2012, Pages 469-479

  Tynan, Ross J ^a,b,c   Weidenhofer, Judith ^a,b,c   Hinwood, Madeleine ^a,b,c   Cairns, Murray J ^a,b,c,d   Day, Trevor A ^a,b,c   Walker, Frederick R ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Anti inflammatory; Antidepressant; BV 2; LPS; Microglia; Nitric oxide; SNRI; SSRI; TNF

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CITALOPRAM; CYCLIC AMP; FLUOXETINE; FLUVOXAMINE MALEATE; NITRIC OXIDE; PAROXETINE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; DRUG SCREENING; IC 50; INTRACELLULAR SIGNALING; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CELLS, CULTURED; CYCLOHEXANOLS; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE; NOREPINEPHRINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857192442     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.12.011     Document Type: Article

References (51)

1. Amit B.H., Gil-Ad I., Taler M., Bar M., Zolokov A., Weizman A. Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro. Eur. Neuropsychopharmacol. 2009, 19:726-734.
2. Baune B.T., Dannlowski U., Domschke K., Janssen D.G., Jordan M.A., Ohrmann P., Bauer J., Biros E., Arolt V., Kugel H., Baxter A.G., Suslow T. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol. Psychiatry 2010, 67:543-549.
3. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 1990, 27:229-237.
4. Bolo N.R., Hode Y., Nedelec J.F., Laine E., Wagner G., Macher J.P. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 2000, 23:428-438.
5. Cerri A.P., Arosio B., Viazzoli C., Confalonieri R., Teruzzi F., Annoni G. 308(G/A) TNF-alpha gene polymorphism and risk of depression late in the life. Arch. Gerontol. Geriatr. 2009, 49(Suppl. 1):29-34.
6. Cerri A.P., Arosio B., Viazzoli C., Confalonieri R., Vergani C., Annoni G. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. Int. J. Geriatr. Psychiatry 2010, 25:219-223.
7. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Higgins J.P., Churchill R., Watanabe N., Nakagawa A., Omori I.M., McGuire H., Tansella M., Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009, 373:746-758.
8. Dello Russo C., Boullerne A.I., Gavrilyuk V., Feinstein D.L. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J. Neuroinflamm. 2004, 1:9.
9. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
10. Ellis P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust. N Z J. Psychiatry 2004, 38:389-407.
11. Galecki P., Florkowski A., Bienkiewicz M., Szemraj J. Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients. Neuropsychobiology 2010, 62:116-120.
12. Graeber M.B. Changing face of microglia. Science (New York, N.Y) 2010, 330:783-788.
13. Ha E., Jung K.H., Choe B.K., Bae J.H., Shin D.H., Yim S.V., Baik H.H. Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci. Lett. 2006, 397:185-189.
14. Hannestad J., DellaGioia N., Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011, 36:2452-2459.
15. Hashioka S., Klegeris A., Monji A., Kato T., Sawada M., McGeer P.L., Kanba S. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 2007, 206:33-42.
16. Hashioka S., McGeer P.L., Monji A., Kanba S. Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9:12-19.
17. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996, 29:2-11.
18. Henn A., Lund S., Hedtjarn M., Schrattenholz A., Porzgen P., Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 26:83-94.
19. Henry M.E., Schmidt M.E., Hennen J., Villafuerte R.A., Butman M.L., Tran P., Kerner L.T., Cohen B., Renshaw P.F. A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 2005, 30:1576-1583.
20. Hickie I., Lloyd A. Are cytokines associated with neuropsychiatric syndromes in humans?. Int. J. Immunopharmacol. 1995, 17:677-683.
21. Hinwood M., Morandini J., Day T.A., Walker F.R. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 2011.
22. Hong C.J., Yu Y.W., Chen T.J., Tsai S.J. Interleukin-6 genetic polymorphism and Chinese major depression. Neuropsychobiology 2005, 52:202-205.
23. Horikawa H., Kato T.A., Mizoguchi Y., Monji A., Seki Y., Ohkuri T., Gotoh L., Yonaha M., Ueda T., Hashioka S., Kanba S. Inhibitory effects of SSRIs on IFN-gamma induced microglial activation through the regulation of intracellular calcium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1306-1316.
24. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
25. Hwang J., Zheng L.T., Ock J., Lee M.G., Kim S.H., Lee H.W., Lee W.H., Park H.C., Suk K. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008, 55:826-834.
26. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Hsu C.D., Liou Y.J. Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromol. Med. 2009, 11:322-327.
27. Imai Y., Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002, 40:164-174.
28. Innamorato N.G., Rojo A.I., Garcia-Yague A.J., Yamamoto M., de Ceballos M.L., Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 2008, 181:680-689.
29. Janssen D.G., Caniato R.N., Verster J.C., Baune B.T. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum. Psychopharmacol. 2010, 25:201-215.
30. Lacasse J.R., Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med. 2005, 2:e392.
31. Li P., Lu J., Kaur C., Sivakumar V., Tan K.L., Ling E.A. Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells. Neuroscience 2009, 164:948-962.
32. Liu D., Wang Z., Liu S., Wang F., Zhao S., Hao A. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 2011, 61:592-599.
33. Lu D.Y., Tsao Y.Y., Leung Y.M., Su K.P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 2010, 35:2238-2248.
34. MacGillivray L., Reynolds K.B., Sickand M., Rosebush P.I., Mazurek M.F. Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 2011, 65:1166-1172.
35. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
36. Mant A., Rendle V.A., Hall W.D., Mitchell P.B., Montgomery W.S., McManus P.R., Hickie I.B. Making new choices about antidepressants in Australia: the long view 1975-2002. Med. J. Aust. 2004, 181:S21-24.
37. Martensson U., Nassberger L. Influence of antidepressants on mitogen stimulation of human lymphocytes. Toxicol. In Vitro 1993, 7:241-245.
38. Obuchowicz E., Kowalski J., Labuzek K., Krysiak R., Pendzich J., Herman Z.S. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int. J. Neuropsychopharmacol. 2006, 9:27-35.
39. Owens M.J., Morgan W.N., Plott S.J., Nemeroff C.B. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 1997, 283:1305-1322.
40. Sacerdote P., Bianchi M., Panerai A.E. Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis in vitro. Gen. Pharmacol. 1994, 25:409-412.
41. Sebire G., Emilie D., Wallon C., Hery C., Devergne O., Delfraissy J.F., Galanaud P., Tardieu M. In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol. 1993, 150:1517-1523.
42. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., Mirnics K. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 2011, 16:751-762.
43. Tynan R.J., Naicker S., Hinwood M., Nalivaiko E., Buller K.M., Pow D.V., Day T.A., Walker F.R. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 2010, 24:1058-1068.
44. Wager-Smith K., Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neurosci. Biobehav. Rev. 2011, 35:742-764.
45. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
46. Wohleb E.S., Hanke M.L., Corona A.W., Powell N.D., Stiner L.M., Bailey M.T., Nelson R.J., Godbout J.P., Sheridan J.F. Beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011, 31:6277-6288.
47. Wong M.L., Dong C., Maestre-Mesa J., Licinioa J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 2008, 13:800-812.
48. Xia Z., Depierre J.W., Nassberger L. The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J. Pharm. Pharmacol. 1996, 48:115-116.
49. Xia Z., DePierre J.W., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996, 34:27-37.
50. Yoshikawa M., Suzumura A., Ito A., Tamaru T., Takayanagi T. Effect of phosphodiesterase inhibitors on nitric oxide production by glial cells. Tohoku J. Exp. Med. 2002, 196:167-177.
51. Yoshikawa M., Suzumura A., Tamaru T., Takayanagi T., Sawada M. Effects of phosphodiesterase inhibitors on cytokine production by microglia. Mult. Scler. 1999, 5:126-133.